Mary Caffrey

Catalyst for Payment Reform will use 3 states to pilot new metrics to measure how well healthcare transformation is penetrating individual markets.

The biologic dupilumab had a breakthrough designation when it received FDA approval earlier this year.

Researchers have focused on changes in the gut bacteria to figure out who is at risk for a loss of beta cell function.

The editors cited limits on research by CDC and called on physicians to be more proactive in screening for the presence of guns in homes of those at high risk for suicide.

Healthcare experts increasingly recognize that behavioral science will provide the ideas for reducing the $245 billion annual cost of diabetes in the United States.

The US Preventive Services Task Force already has recommendations for screening and intervention for obesity, but they often are not followed.

Scaling behavioral change and reducing diabetes at the population level were major themes of the meeting.

The announcement does not affect LifeScan, which makes blood glucose management tools and apps. Company officials said an exclusivity deal between Medtronic and UnitedHealthcare was among the factors that contributed to the decision.

The former CMS administrator, who coined the term "the Triple Aim," offered a vision for the next era of healthcare innovation at a summit presented by Horizon Blue Cross Blue Shield of New Jersey.

The fight for dominance of the market for a costly cholesterol drug continues, even as sales fall short of expectations.

The recommendation is the first step toward making the therapy widely available to patients in England and Wales.

The review of 28 studies found that night shift workers were at particularly high risk of developing the type of abdominal obesity associated with heart disease.

The study was based on 12 years' worth of data from a national survey.

The author, who has lived with type 1 diabetes for 16 years, offers practical advice on food, exercise, mindset, and sleep.

The filing also seeks new indications for fixed-dose combinations of canagliflozin and metformin.

This is the second year in a row that the prize in Medicine or Physiology has been awarded for work that yielded understanding of chronic disease.

The CEO said the changes will finally allow the company to set the inhaled insulin apart from its rivals.

A GAO report faults CMS policy on durable medical equipment, and the diaTribe Foundation convenes a daylong session to guide the FDA on how future drugs and devices should be evaluated for measures beyond A1C.

Coverage of technology developments at the 77th Scientific Sessions of the American Diabetes Association (ADA) and the annual meeting of the American Association of Diabetes Educators (AADE).

President Donald Trump had clearly been unhappy with the negative press coverage over Price's use of charter flights for routine travel. The HHS Secretary said Thursday he would pay for his seats, or $52,000 of the $400,000 cost of the 26 charter flights taken since May.

A continuous glucose monitor (CGM) device made in the United States is finally approved for use here after patients in 40 other countries already have access.

The National Quality Forum report finds that good payment models are key to promoting health equity; it states health systems must be compensated for taking care of more complex patients.

As obesity rates increase, health systems will have to take charge of finding places to discharge the largest patients to avoid penalties from Medicare, authors of a new study find.

The pilot program is the latest venture among stakeholders in diabetes care to look for ways to deploy patient data to improve outcomes and hold down costs.

Collins cited projections for large cuts to Medicaid in explaining her opposition to the proposal.

During a presentation at the US Psychiatric and Mental Health Congress in New Orleans, Louisiana, Mark Zimmerman, MD, said studies show that the presence of a comorbid disorder or specific symptom were the most important factors driving treatment decisions when clinicians picked an antidepressant, and anxiety was the symptom they cited most frequently.

With so many options for treatment-resistant depression, expert George Papakostas, MD, said all things being equal, the patient's preference counts.

A primary care physician finds there's little incentive to keep up with a patient-centered medical home, except that it's the right thing to do.

The move to give entrepreneurs access to patient-approved continuous glucose monitoring data fits with the company's prediction that insulin pumps will become a thing of the past, and most of the heavy lifting of delivery will be done by a smartphone.

The growing importance of quality ratings will put pressure on hospitals to meet ADA standards for insulin therapy without added manpower.